Vitamin e loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson's disease by reducing oxidative stress

Nanotechnology

Volumn 25, Issue 48, 2014, Pages

  Pangeni, Rudra ^a   Sharma, Shrestha ^a   Mustafa, Gulam ^a   Ali, Javed ^a   Baboota, Sanjula ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

high pressure homogenization; nanoemulsion; phase diagram; release study

Indexed keywords

ANTIOXIDANTS; BIOCHEMISTRY; DRUG PRODUCTS; EMULSIFICATION; HOMOGENIZATION METHOD; NEURODEGENERATIVE DISEASES; PHASE DIAGRAMS; REFRACTIVE INDEX; SURFACE ACTIVE AGENTS; ZETA POTENTIAL;

ANTI-OXIDANT ACTIVITIES; HIGH PRESSURE HOMOGENIZATION; NANOEMULSION; PHARMACOKINETIC STUDIES; PHARMACOLOGICAL ACTIVITY; RELEASE STUDY; SPONTANEOUS EMULSIFICATION; TERNARY PHASE DIAGRAMS;

RESVERATROL;

ALPHA TOCOPHEROL; ANTIOXIDANT; EMULSION; NANOPARTICLE; POLYSORBATE; RESVERATROL; STILBENE DERIVATIVE;

ANIMAL; BIOAVAILABILITY; BRAIN; DRUG EFFECTS; EMULSION; FEMALE; MALE; MEDICINAL CHEMISTRY; OXIDATIVE STRESS; PARKINSON DISEASE; PARTICLE SIZE; PHARMACOLOGY; PIG; RAT; SOLUBILITY; VISCOSITY; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; BRAIN; CHEMISTRY, PHARMACEUTICAL; EMULSIONS; FEMALE; MALE; NANOPARTICLES; OXIDATIVE STRESS; PARKINSON DISEASE; PARTICLE SIZE; POLYSORBATES; RATS; RATS, WISTAR; SOLUBILITY; STILBENES; SWINE; VISCOSITY; VITAMIN E;

EID: 84910637461     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/25/48/485102     Document Type: Article

References (31)

1. Ahmad M P, Arshad H, Kalam N A, Anshu M, Hasin A M and Shadma W 2012 Effect of the aqueous extract of Mentha arvensis on haloperidol induced catalepsy in albino mice J. Clin. Diagn. Res. 6 542-6
2. Beauchamp C and Fridovich I 1971 Superoxide dismutase: improved assays and an assay applicable to acrylamide gels Anal. Biochem. 44 276-87
3. Campos F F, Campmany A C C, Delgado G R, Serrano O L and Naveros B C 2012 Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis ultrastructural effects and release studies J. Pharm. Sci. 101 3739-52
4. Chopra K, Medhi B and Prakash A 2013 Granulocyte-colony stimulating factor improves Parkinson's disease associated with co-morbid depression: An experimental exploratory study Ind. J. Pharmcol. 45 612-5
5. Dhuria S V, Hanson L R and Frey W H 2009 Intranasal delivery to the central nervous system: mechanisms and experimental considerations J. Pharm. Sci. 99 1654-73
6. Fahn S 2005 Does levodopa slow or hasten the rate of progression of Parkinson's disease? J. Neurol. 252 37-42 IV/
7. Ganta S, Devalapally H and Amiji M 2010 Curcumin enhances oral bioavailability and anti-tumor therapeutic efficacy of paclitaxel upon administration in nanoemulsion formulation J. Pharm. Sci. 99 4630-41
8. Haque S, Md S, Fazi M, Kumar M, Sahni J K, Ali J and Baboota S 2012 Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation Carbohydr. Polym. 89 72-9
9. Hauser D N and Hastings T G 2013 Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism Neurobiol. Dis. 51 35-42
10. Hirsch E C, Jenner P and Przedborski S 2013 Pathogenesis of Parkinson's disease Movement Disord. 28 24-30
11. Jin F, Wu Q, Lu Y F, Gong Q H and Shi J S 2008 Neuroprotective effect of resveratrol on 6-OHDA induced Parkinson's disease in rats Eur. J. Pharmacol. 600 78-82
12. Khan M M et al 2010 Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease Brain Res. 1328 139-51
13. Koroleva M Y and Yurtov E V 2012 Nanoemulsions: the properties, method of preparation and promising applications Russ. Chem. Reviews 81 21-43
14. Kumar A, Ahuja A, Ali J and Baboota S 2012 Curcumin loaded nano globules for solubility enhancement: Preparation, characterization and ex vivo release study J. Nanosci. Nanotechnol. 12 1-10
15. Mittal D, Ali A, Md S, Baboota S, Sahni J K and Ali J 2014 Insights into direct nose to brain delivery: current status and future perspective Drug Deliv 21 75-86
16. Mustafa G, Kumar N, Singh T, Baboota S, Ali J, Bhatnagar A and Ahuja A 2012 Effect of homogenization on the fate of true nanoemulsion in brain translocation: a gamma scintigraphic evaluation Sci. Adv. Material 4 739-48
17. Mustafa G, Baboota S, Ahuja A and Ali J 2012 Formulation development of chitosan coated intra nasal ropinirole nanoemulsion for better management option of Parkinsons: an in vitro-ex vivo evaluation Current Nanoscience 8 348-60
18. Olanow C W and Tatton W G 1999 Etiology and pathogenesis of Parkinson's disease Annu. Rev. Neurosci. 22 123-44
19. Pardeshi C V and Belgamwar V S 2013 Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting Expert Opin. Drug Deliv. 10 957-72
20. Peterson L J and Flood P M 2012 Oxidative stress and microglial cells in Parkinson's disease Mediators Inflamm. 2012 1-12
21. Rex A, Schickert R and Fink H 2004 Antidepressant-like effect of nicotinamide adenine dinucleotide in the forced swim test in rats Pharmacol. Biochem. Behav. 77 303-7
22. Schapira A H V and Olanow C W 2003 Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease Annals Neuro. 53 S149-59
23. Sedlak J and Lindsay R H 1968 Estimation of total, protein bound and non protein sulfhydryl group in tissue with Ellman's reagent Anal. Biochem. 25 192-205
24. Shadab M, Haque S, Fazil M, Kumar M, Baboota S, Sahni J K and Ali J 2014 Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC/mass spectrometry method Expert Opin. Drug Deliv. 11 1-16
25. Sharma S, Sahni J K, Ali J and Baboota S 2014 Effect of high-pressure homogenization on formulation of TPGS loaded nanoemulsion of rutin-pharmacodynamic and antioxidant studies Drug Delivery
26. Szabo G 2009 A glass of red wine to improve mitochondrial biogenesis? novel mechanisms of resveratrol Am. J. Physiol. Heart. Circ. Physiol 297 H8-9
27. Utley H C, Bernheim F and Hochslein P 1967 Effect of sulfhydryl reagent on peroxidation in microsome Arch. Biochem. Biophys. 260 521-31
28. Verma R and Nehru B 2009 Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease Neurochem. Int. 55 369-75
29. Walle T, Hsieh F, Delegge M H, Oatis J E and Walle U K 2004 High absorption but very low bioavailability of oral resveratrol in humans Drug Metabol. Dispos. 32 1377-82
30. Wang Y, Xu H, Fu Q, Ma R and Xiang J 2011 Protective effect of resveratrol from Polygonum cuspidatum and its liposomal form on nigral cells in Parkinsonian rats J. Neurolo. Sci. 304 29-34
31. Zigmond M J and Burke R E 2002 Pathophysiology of Parkinson's disease Neuropsychopharmacology: The Fifth Generation of Progress 1781-93